Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

119 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Letter: faecal microbiota transplantation for irritable bowel syndrome. Authors' reply.
Lahtinen P, Jalanka J, Hartikainen A, Mattila E, Hillilä M, Punkkinen J, Koskenpato J, Anttila VJ, Tillonen J, Satokari R, Arkkila P. Lahtinen P, et al. Among authors: arkkila p. Aliment Pharmacol Ther. 2020 Aug;52(3):557-558. doi: 10.1111/apt.15875. Aliment Pharmacol Ther. 2020. PMID: 32656839 No abstract available.
Rifaximin in the treatment of recurrent Clostridium difficile infection.
Mattila E, Arkkila P, Mattila PS, Tarkka E, Tissari P, Anttila VJ. Mattila E, et al. Among authors: arkkila p. Aliment Pharmacol Ther. 2013 Jan;37(1):122-8. doi: 10.1111/apt.12111. Epub 2012 Oct 24. Aliment Pharmacol Ther. 2013. PMID: 23095030 Free article.
Extraintestinal Clostridium difficile infections.
Mattila E, Arkkila P, Mattila PS, Tarkka E, Tissari P, Anttila VJ. Mattila E, et al. Among authors: arkkila p. Clin Infect Dis. 2013 Sep;57(6):e148-53. doi: 10.1093/cid/cit392. Epub 2013 Jun 13. Clin Infect Dis. 2013. PMID: 23771984
Outcome after discontinuation of TNFα-blocking therapy in patients with inflammatory bowel disease in deep remission.
Molander P, Färkkilä M, Salminen K, Kemppainen H, Blomster T, Koskela R, Jussila A, Rautiainen H, Nissinen M, Haapamäki J, Arkkila P, Nieminen U, Kuisma J, Punkkinen J, Kolho KL, Mustonen H, Sipponen T. Molander P, et al. Among authors: arkkila p. Inflamm Bowel Dis. 2014 Jun;20(6):1021-8. doi: 10.1097/MIB.0000000000000052. Inflamm Bowel Dis. 2014. PMID: 24798636 Clinical Trial.
Does fecal calprotectin predict short-term relapse after stopping TNFα-blocking agents in inflammatory bowel disease patients in deep remission?
Molander P, Färkkilä M, Ristimäki A, Salminen K, Kemppainen H, Blomster T, Koskela R, Jussila A, Rautiainen H, Nissinen M, Haapamäki J, Arkkila P, Nieminen U, Kuisma J, Punkkinen J, Kolho KL, Mustonen H, Sipponen T. Molander P, et al. Among authors: arkkila p. J Crohns Colitis. 2015 Jan;9(1):33-40. doi: 10.1016/j.crohns.2014.06.012. J Crohns Colitis. 2015. PMID: 25052347 Clinical Trial.
119 results